Business Services Industry

No magic potion; State life-science companies look for ways to survive, not a magic formula for success.

Crain's Detroit Business, June, 2002 by Dietderich, Andrew

Becoming the next Pfizer Inc., Merck & Co. or Bristol-Myers Squibb Co. isn't the first concern of the state's growing number of life-science companies. They're more concerned with looking for ways to sustain their businesses while facing a limited supply of state funding and the costly, arduous task of obtaining regulatory approval.

The goal? To survive a sluggish economy as they continue to push products through the invention stage to eventually land in medicine cabinets, on store shelves or in doctors' offices or hospitals. The key? Successfully tapping enough sources of money, from grants to investors to selling or licensing parts of their business, said experts such as Lisa Kurek, managing partner of Ann Arbor-based Biotechnology Business...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here